Germ line BRCA1 and/or BRCA2 mutations were screened in 50 Turkish breast and/or ovarian cancer patients composed of hereditary, familial, early onset and male cancer groups. Genomic DNA samples were tested by heteroduplex analysis and DNA sequencing. Two truncating BRCA2 mutations, one novel (6880 insG) and one previously reported (3034 delAAAC), were found in two out of six (33%) hereditary breast and/or ovarian cancer patients. A novel truncating (1200 insA) and a missense (2080A→G) BRCA1 mutation was found in two of 27 (7%) individuals in the early onset group. A total of four (8%) disease-causing mutations in 50 breast cancer patients were identified in BRCA1 and BRCA2 genes. In addition, five BRCA1 sequence variants have been identifi...
BRCA1/2 mutations play a significant role in cancer pathogenesis and predisposition particularly in ...
Objectives To find BRCA1/2 test selection criteria unique to the Turkish population, as well as to p...
Breast cancer is the most common female cancer in Morocco. About 5 to 10% are due to hereditary pred...
BRCA1 and BRCA2 gene mutations in patients with breast and/or ovarian cancer have been not character...
Cataloged from PDF version of article.Germ line BRCA1 and/or BRCA2 mutations were screened in 50 Tur...
To date, BRGA1 and BRCA2 mutations in breast and/or ovarian patients have not been characterized in ...
WOS: 000285678300006The germline mutations of breast cancer susceptibility genes 1 (BRCA1) and 2 (BR...
It is well established that mutations in BRCA1 and BRCA2 genes significantly increase the risk of br...
The germline mutations of breast cancer susceptibility genes 1 (BRCA1) and 2 (BRCA2) are the two mos...
Purpose: Pathogenic/likely pathogenic (P/LP) germline variations in BRCA1 and BRCA2 genes are respon...
Background. The guidelines recommend considering the BRCA1 and BRCA2 germline mutations in female pa...
PubMedID: 31228304Certain genetic predisposition factors, such as BRCA1 and BRCA2 mutations play a p...
Ovarian cancer is a clinically important cancer in Turkey. The contribution of BRCA1 and BRCA2 to ov...
Objectives To find BRCA1/2 test selection criteria unique to the Turkish population, as well as to p...
Abstract In the present study, mutations in BRCA1 and BRCA2, the two major genes predisposing indivi...
BRCA1/2 mutations play a significant role in cancer pathogenesis and predisposition particularly in ...
Objectives To find BRCA1/2 test selection criteria unique to the Turkish population, as well as to p...
Breast cancer is the most common female cancer in Morocco. About 5 to 10% are due to hereditary pred...
BRCA1 and BRCA2 gene mutations in patients with breast and/or ovarian cancer have been not character...
Cataloged from PDF version of article.Germ line BRCA1 and/or BRCA2 mutations were screened in 50 Tur...
To date, BRGA1 and BRCA2 mutations in breast and/or ovarian patients have not been characterized in ...
WOS: 000285678300006The germline mutations of breast cancer susceptibility genes 1 (BRCA1) and 2 (BR...
It is well established that mutations in BRCA1 and BRCA2 genes significantly increase the risk of br...
The germline mutations of breast cancer susceptibility genes 1 (BRCA1) and 2 (BRCA2) are the two mos...
Purpose: Pathogenic/likely pathogenic (P/LP) germline variations in BRCA1 and BRCA2 genes are respon...
Background. The guidelines recommend considering the BRCA1 and BRCA2 germline mutations in female pa...
PubMedID: 31228304Certain genetic predisposition factors, such as BRCA1 and BRCA2 mutations play a p...
Ovarian cancer is a clinically important cancer in Turkey. The contribution of BRCA1 and BRCA2 to ov...
Objectives To find BRCA1/2 test selection criteria unique to the Turkish population, as well as to p...
Abstract In the present study, mutations in BRCA1 and BRCA2, the two major genes predisposing indivi...
BRCA1/2 mutations play a significant role in cancer pathogenesis and predisposition particularly in ...
Objectives To find BRCA1/2 test selection criteria unique to the Turkish population, as well as to p...
Breast cancer is the most common female cancer in Morocco. About 5 to 10% are due to hereditary pred...